Drug-based Therapy

OTOSTEM employs human stem cells to generate human otic cellular models to allow screening for ototoxic, otoprotective and otoregenerative compounds to develop a drug-based hearing loss treatment.

Cell-based Therapy

OTOSTEM addresses this urgent and unmet medical need for causal hearing loss therapies by focusing on human stem cell technology.

We will follow two major directions to implement a therapeutic use of human stem cell technology for hearing loss.

Human Stem Cell Technology

Stacks Image 808
We will follow two major directions to implement a therapeutic use of human stem cell technology for hearing loss.

Welcome to the OTOSTEM Website

The lack of human otic cell models represents a significant roadblock hampering the development of drug-based or cell-based therapies. Hearing impairment is the most frequent
human sensory deficit and is mainly caused by the irreversible loss of neurosensory cells in the cochlea.

OTOSTEM addresses this urgent and unmet medical need for causal hearing loss therapies by focusing on human stem cell technology.

Co-funded by the European Union